Sex and race disparities found in management of patients with hypertrophic cardiomyopathy in the hospital

ROCHESTER, Minn. — In recent decades, implantable cardioverter-defibrillator (ICD) use in the management of patients with hypertrophic cardiomyopathy (HCM) has increased. However, a new Mayo Clinic study finds that ICDs are not used as often for female patients and patients of color. Data from the National Inpatie nt Sample, an all-payer administrative database of inpatient hospitalizations, showed disparities regarding which patients commonly receive this therapy in the hospital. The data also revealed regional variations in the…
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news